Table 2.
List of tentatively identified compounds by GC-MS in incubation-shaking cabinet after 192 and 312 h.
| No. | Retention Index | Similarity (%) | Proportion(%) | Identified Compound | Molar Weight | |||
|---|---|---|---|---|---|---|---|---|
| EIS192 | EIS312 | EIS192 | EIS312 | EIS192 | EIS312 | |||
| 1 | 1335 | n.d. | 95 | n.d. | 0.10 | n.d. | Nonanoic acid, TMS derivative | 230 |
| 2 | 1444 | 1379 | 94 | 92 | 0.03 | 0.03 | Decanoic acid, TMS derivative | 244 |
| 3 | n.d. | 1448 | n.d. | 75 | n.d. | 0.01 | Butanedioic acid, TMS derivate | 350 |
| 4 | 1650 | 1630 | 93 | 95 | 0.04 | 0.05 | Dodecanoic acid, TMS derivative | 272 |
| 5 | 1691 | n.d. | 93 | n.d. | 0.02 | n.d. | Tetradecanenitrile | 209 |
| 6 | 1751 | 1739 | 88 | 93 | 0.03 | 0.13 | Tridecanoic acid, TMS derivative | 286 |
| 7 | 1787 | 1773 | 86 | 92 | 0.01 | 0.22 | Loliolide, TMS | 268 |
| 8 | 1805 | 1796 | 88 | 80 | 0.05 | 0.02 | Azelaic acid, 2TMS derivative | 332 |
| 9 | n.d. | 1831 | n.d. | 86 | n.d. | 0.06 | Myristoleic acid, trimethylsilyl ester | 298 |
| 10 | 1852 | 1845 | 95 | 96 | 1.59 | 5.12 | Myristic acid, TMS derivative | 300 |
| 11 | 1877 | n.d. | 94 | n.d. | 0.08 | n.d. | Palmitoleonitrile | 235 |
| 12 | 1898 | n.d. | 96 | n.d. | 0.19 | n.d. | Heptadecanenitrile | 251 |
| 13 | n.d. | 1956 | n.d. | 82 | n.d. | 0.03 | Hexadecanenitrile | 251 |
| 14 | 1951 | 1947 | 93 | 94 | 0.10 | 0.23 | Pentadecanoic acid, TMS derivative | 314 |
| 15 | n.d. | 1960 | n.d. | 93 | n.d. | 0.05 | 1-Hexadecanol, TMS derivative | 314 |
| 16 | 1968 | 1964 | 96 | 95 | 0.66 | 0.25 | Tetradecanamide | 227 |
| 17 | 2031 | 2026 | 88 | 96 | 1.63 | 7.89 | Palmitelaidic acid, TMS | 326 |
| 18 | 2052 | 2049 | 96 | 96 | 1.65 | 2.07 | Palmitic acid, TMS derivative | 328 |
| 19 | 2076 | n.d. | 89 | n.d. | 0.43 | n.d. | 9-Octadecynenitrile | 261 |
| 20 | 2082 | 2078 | 97 | 97 | 6.10 | 0.37 | (Z)-9-Octadecenenitrile | 263 |
| 21 | 2151 | 2149 | 91 | 80 | 0.04 | 0.02 | Heptadecanoic acid, trimethylsilyl ester | 342 |
| 22 | 2158 | 2155 | 97 | 96 | 0.97 | 0.36 | Palmitoleamide | 253 |
| 23 | n.d. | 2161 | n.d. | 86 | n.d. | 0.05 | 1-Octadecanol, TMS derivative | 342 |
| 24 | 2178 | 2176 | 98 | 97 | 1.93 | 0.52 | Hexadecanamide | 255 |
| 25 | 2184 | 2183 | 93 | 97 | 0.20 | 2.06 | Phytol, TMS derivative | 368 |
| 26 | n.d. | 2213 | n.d. | 88 | n.d. | 0.24 | Linoleic, TMS derivative | 352 |
| 27 | 2251 | 2250 | 95 | 95 | 0.75 | 0.53 | Stearic acid, TMS derivative | 356 |
| 28 | n.d. | 2364 | n.d. | 96 | n.d. | 13,97 | 9-Octadecenamide | 281 |
| 29 | n.d. | 2380 | n.d. | 96 | n.d. | 3.78 | Eicosapentaenoic acid, TMS derivative | 374 |
| 30 | 2427 | 2422 | 84 | 82 | 73.31 | 35,53 | Oleamide, TMS derivative | 353 |
| 31 | 2449 | 2419 | 95 | 95 | 1.37 | 0.75 | Octadecanamide, N-TMS derivate | 355 |
| 32 | 2571 | n.d. | 93 | n.d. | 0.81 | n.d. | 13-Docosenamide, (Z)- | 337 |
| 33 | 2578 | 2577 | 93 | 94 | 0.32 | 1.88 | 2-Palmitoylglycerol, 2TMS derivative | 474 |
| 34 | 2610 | 2610 | 94 | 96 | 0.47 | 6.92 | 1-Monopalmitin, 2TMS derivative | 474 |
| 35 | 2771 | 2771 | 89 | 91 | 1.28 | 2.20 | 2-Monostearin, 2TMS derivative | 502 |
| 36 | 2804 | 2804 | 95 | 96 | 3.52 | 10,64 | Glycerol monostearate, 2TMS derivative | 502 |
| 37 | 2998 | 2997 | 87 | 80 | 0.04 | 0.10 | 2,3-Dihydroxypropyl icosanoate, 2TMS derivative | 530 |
| 38 | 3162 | 3160 | 96 | 96 | 1.21 | 1.97 | Cholesterol, TMS derivative | 458 |
| 39 | 3260 | 3529 | 88 * | 89 * | 1.05 | 1.59 | 24-Methylene cholesterol * | 398 * |
| 40 | n.d. | 3379 | n.d. | 88 | n.d. | 0.13 | Isofucosterol, O-TMS | 484 |
| 41 | n.d. | 3672 | n.d. | 90 | n.d. | 0.22 | Oleanolic acid 2TMS | 600 |
* A compound identified in non-derivatized form and its molecular weight (other data for this compound, RI, and proportion, were obtained for the derivatized form) as well as with literature data comparison for its derivatized form.; n.d.—not detected. EIS192—after 192 h in an incubation-shaking cabinet; EIS312—after 312 h in an incubation-shaking cabinet.